Naveen Jain, the founder of the American company Viome specializing in medical technologies.
2017: About AI role in health care
In the future the artificial intelligence (AI) will play a huge role in health care, is convinced Naveen Jain, the founder of the American startup of Viome specializing in medical technologies.
The interview with the philanthropist and the innovator took place on fields of the international technology forum Slush 2017 which took place in Finland from November 30 to December 1, 2017. Excerpts from it in December, 2017 were published by the CNBC agency.[1]
The startup of Viome founded in 2016 by group of entrepreneurs led by Nevin Dzheyn totals about 45 employees and offers service for intestinal microflora normalization, Healthcare IT News reports.[2]
Clients send Viome to the analysis a sample of the calla, execute houses the metabolic test and fill out the questionnaire about the way of life and health. Using the patented technology confirmed to the Los Alamos national laboratory (Los Alamos National Laboratory), specialists of Viome reveal and count all microorganisms in the client's intestines.
Having analyzed data retrieveds using AI, experts make the individual recommendations about a power supply helping to adjust balance of microflora and to recover the broken GIT functions. Viome says that observance of the made plan is capable to prevent many chronic diseases.
By the beginning of December, 2017 service on initial stage of development also totals several thousands of clients. The cost of a subscription is $59 a month or $599 a year.
Nevin Jane claims that behind similar technologies — the future.
 | This AI tsunami approaches. Sensors become very cheap, and we can glance in an organism and precisely learn what in it occurs — he told CNBC, having added that the artificial intelligence will allow to analyze such amounts of data which people cannot process. |  |
Investors also believe in success of Viome and the AI technologies applied by a startup. Since the beginning of the basis the company attracted about $21 million which are supposed to be aimed at the development of service and scientific research, reported the VentureBeat edition in August, 2017.[3]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |